NIST’s NGS-based dataset helps provide additional information on incomplete or broken down DNA profiles
Country details 2018 government R&D budget
An explanation of the traditional market fundamentals applied to scientific instruments and lab product industries that distribute dividend payments to investors.
R&D spending reverses a two-year decline in growth
Scientific panel discusses the advancement of peptide drug delivery
UK parliament report underlines concerns about university R&D
Winning products exemplify sleek aesthetic design paired with enhanced technical capabilities
Pharma/bio sector drives updated growth forecast for analytical and life science instrument industry
“How can we bring transformative technology to the clinic?”
Major publicly held scientific instrument companies recorded solid organic growth in the first half of this year, despite bumps in the road.
